Petrus Trust Company LTA Invests $649,000 in Xometry, Inc. $XMTR

Key Points

• Petrus Trust Company LTA invested $649,000 in Xometry, Inc. by purchasing 26,033 shares, reflecting a 0.05% ownership in the company.
• Several hedge funds increased their positions in Xometry, with Ameriprise Financial boosting its stake by 225.7% to a total of $36.4 million.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Xometry, with a target price range between $38.00 and $42.00 per share.

Petrus Trust Company LTA purchased a new position in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 26,033 shares of the company's stock, valued at approximately $649,000. Petrus Trust Company LTA owned approximately 0.05% of Xometry as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in XMTR. Ameriprise Financial Inc. boosted its position in shares of Xometry by 225.7% during the fourth quarter. Ameriprise Financial Inc. now owns 852,813 shares of the company's stock worth $36,381,000 after purchasing an additional 590,974 shares in the last quarter. Nuveen LLC bought a new stake in Xometry in the 1st quarter valued at $14,639,000. Next Century Growth Investors LLC lifted its position in Xometry by 194.1% in the 1st quarter. Next Century Growth Investors LLC now owns 664,292 shares of the company's stock valued at $16,554,000 after acquiring an additional 438,393 shares in the last quarter. Polar Capital Holdings Plc bought a new stake in Xometry in the 4th quarter valued at $14,070,000. Finally, Marathon Partners Equity Management LLC bought a new stake in Xometry in the 4th quarter valued at $10,857,000. 97.31% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on XMTR shares. The Goldman Sachs Group boosted their price objective on shares of Xometry from $33.00 to $42.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. JPMorgan Chase & Co. boosted their price objective on shares of Xometry from $36.00 to $38.00 and gave the company an "overweight" rating in a research report on Tuesday, June 3rd. Citigroup reaffirmed an "outperform" rating on shares of Xometry in a research report on Friday, July 11th. UBS Group boosted their price objective on shares of Xometry from $35.00 to $40.00 and gave the company a "neutral" rating in a research report on Wednesday, August 6th. Finally, Cantor Fitzgerald raised shares of Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 price objective on the stock in a research report on Tuesday, August 5th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Xometry currently has a consensus rating of "Moderate Buy" and an average target price of $40.44.

Insider Activity

In other news, CEO Randolph Altschuler sold 9,332 shares of the business's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $32.39, for a total transaction of $302,263.48. Following the transaction, the chief executive officer directly owned 319,602 shares in the company, valued at $10,351,908.78. The trade was a 2.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO James Miln sold 598 shares of the business's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $50.25, for a total transaction of $30,049.50. Following the transaction, the chief financial officer owned 144,115 shares in the company, valued at $7,241,778.75. This represents a 0.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.66% of the stock is owned by insiders.

Xometry Trading Up 1.1%

Shares of NASDAQ:XMTR opened at $49.68 on Friday. The company's 50-day moving average price is $39.92 and its two-hundred day moving average price is $32.30. The company has a debt-to-equity ratio of 1.20, a current ratio of 3.91 and a quick ratio of 3.85. Xometry, Inc. has a one year low of $16.11 and a one year high of $51.68. The stock has a market capitalization of $2.52 billion, a PE ratio of -40.39 and a beta of 0.87.

Xometry (NASDAQ:XMTR - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.05 by $0.04. Xometry had a negative net margin of 10.20% and a negative return on equity of 6.79%. The firm had revenue of $162.55 million for the quarter, compared to analysts' expectations of $156.53 million. During the same period in the previous year, the firm posted ($0.01) EPS. The company's revenue for the quarter was up 22.6% on a year-over-year basis. Xometry has set its Q3 2025 guidance at EPS. On average, equities analysts forecast that Xometry, Inc. will post -0.66 EPS for the current fiscal year.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.